* U.S. FDA has granted accelerated approval of Venclexta (venetoclax) tablets for patients diagnosed with chronic lymphocytic leukemia
The post CORRECTED-BRIEF-AbbVie says FDA granted accelerated approval of Venclexta tablets appeared first on NASDAQ.